Changes in zinc status and zinc transporters expression in whole blood of patients with Systemic Inflammatory Response Syndrome (SIRS)

Journal of Trace Elements in Medicine and Biology

Volumn 49, Issue , 2018, Pages 202-209

  Florea, Daniela ^a,b   Molina López, Jorge ^a   Hogstrand, Christer ^c   Lengyel, Imre ^d   de la Cruz, Antonio Pérez ^e   Rodríguez Elvira, Manuel ^e   Planells, Elena ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Critically ill patients; Severity; Systemic inflammatory response syndrome (SIRS); Zinc level; Zinc transporters

Indexed keywords

ALBUMIN; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP3 PROTEIN; ZIP4 PROTEIN; ZIP8 PROTEIN; ZNT1 PROTEIN; ZNT4 PROTEIN; ZNT5 PROTEIN; ZNT6 PROTEIN; ZNT7 PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; ZINC-BINDING PROTEIN;

ADULT; ALBUMIN LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SPAIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ZINC BLOOD LEVEL; ZINC DEFICIENCY; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS;

BIOMARKERS; CARRIER PROTEINS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ZINC;

EID: 85035330672     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2017.11.013     Document Type: Article

References (30)

1. Hogstrand, C., Maret, W., Genetics of Human Zinc Deficiencies, eLS. 2016, John Wiley & Sons Ltd, Chichester.
2. Robert, R., John, B., Robert, C., John, D.T., Guylaine, F., Sean, L., Michael, H.K., James, P., Catherine, R.A., Barbara, S., John, S.W., Judith, T.R., Keith, W.p., Stanley, Z.H., DRI – Reference Intake- Vitamin Full Report., 2001 Washington.
3. Abilés, J., de la Cruz, A.P., Castaño, J., Rodríguez-Elvira, M., Aguayo, E., Moreno-Torres, R., Llopis, J., Aranda, P., Argüelles, S., Ayala, A., de la Quintana, A.M., Planells, E.M., Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit. Care, 10(5), 2006, R146.
4. Besecker, B.Y., Exline, M.C., Hollyfield, J., Phillips, G., Disilvestro, R.A., Wewers, M.D., Knoell, D.L., A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am. J. Clin. Nutr. 93:6 (2011), 1356–1364.
5. Prasad, A.S., Beck, F.W., Snell, D.C., Kucuk, O., Zinc in cancer prevention. Nutr. Cancer 61:6 (2009), 879–887.
6. Cander, B., Dundar, Z.D., Gul, M., Girisgin, S., Prognostic value of serum zinc levels in critically ill patients. J. Crit. Care 26:1 (2011), 42–46.
7. Knoell, D.L., Liu, M.J., Impact of zinc metabolism on innate immune function in the setting of sepsis. Int. J. Vitam. Nutr. Res. 80:4–5 (2010), 271–277.
8. Foster, M., Samman, S., Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 4:7 (2012), 676–694.
9. Mertens, K., Lowes, D.A., Webster, N.R., Talib, J., Hall, L., Davies, M.J., Beattie, J.H., Galley, H.F., Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation. Br. J. Anaesth. 114:6 (2015), 990–999.
10. King, J.C., Zinc: an essential but elusive nutrient. Am. J. Clin. Nutr. 94:2 (2011), 679S–684S.
11. Lowe, N.M., Fekete, K., Decsi, T., Methods of assessment of zinc status in humans: a systematic review. Am. J. Clin. Nutr. 89:6 (2009), 2040S–2051S.
12. Lowe, N.M., Assessing zinc in humans. Curr. Opin. Clin. Nutr. Metab. Care, 2016.
13. Lichten, L.A., Cousins, R.J., Mammalian zinc transporters: nutritional and physiologic regulation. Annu. Rev. Nutr. 29 (2009), 153–176.
14. Foster, M., Hancock, D., Petocz, P., Samman, S., Zinc transporter genes are coordinately expressed in men and women independently of dietary or plasma zinc. J. Nutr. 141:6 (2011), 1195–1201.
15. Harris, E.D., Cellular transporters for zinc. Nutr. Rev. 60:4 (2002), 121–124.
16. Mataix, J., Ergon, S.A., (eds.) Verdu Nutricion y alimentacion Humana, vols. 1 and 2, 2009, Cartone, Spain.
17. Singer, P., Berger, M.M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., Pichard, C., ESPEN, ESPEN guidelines on parenteral nutrition: intensive care. Clin. Nutr. 28:4 (2009), 387–400.
18. Gómez, M., Rodríguez, I., Cámara, C., Palacios, M.A., Evaluation of biological sample mineralisation methods for the determination of fluorine by graphite furnace molecular absorption spectrometry. Analyst 115:5 (1990), 553–557.
19. English, J.L., Hambidge, K.M., Plasma and serum zinc concentrations: effect of time between collection and separation. Clin. Chim. Acta 175:3 (1988), 211–215.
20. Fontaine, E., Müller, M.J., Adaptive alterations in metabolism: practical consequences on energy requirements in the severely ill patient. Curr. Opin. Clin. Nutr. Metab. Care 14:2 (2011), 171–175.
21. Phillips, G.D., Garnys, V.P., Trace element balance in adults receiving parenteral nutrition: preliminary data. J. Parenter. Enteral. Nutr. 5:1 (1981), 11–14.
22. Phillips, G.D., Garnys, V.P., Parenteral administration of trace elements to critically ill patients. Anaesth. Intensive Care 9:3 (1981), 221–225.
23. Cvijanovich, N.Z., King, J.C., Flori, H.R., Gildengorin, G., Wong, H.R., Zinc homeostasis in pediatric critical illness. Pediatr. Crit. Care Med. 10:1 (2009), 29–34.
24. Wong, H.R., Shanley, T.P., Sakthivel, B., Cvijanovich, N., Lin, R., Allen, G.L., Thomas, N.J., Doctor, A., Kalyanaraman, M., Tofil, N.M., Penfil, S., Monaco, M., Tagavilla, M.A., Odoms, K., Dunsmore, K., Barnes, M., Aronow, B.J., G.o.P.S.S.S. Investigators, Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genom. 30:2 (2007), 146–155.
25. Frederickson, C.J., Maret, W., Cuajungco, M.P., Zinc and excitotoxic brain injury: a new model. Neuroscientist 10:1 (2004), 18–25.
26. Kambe, T., Hashimoto, A., Fujimoto, S., Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell. Mol. Life Sci. 71:17 (2014), 3281–3295.
27. Liang, D., Xiang, L., Yang, M., Zhang, X., Guo, B., Chen, Y., Yang, L., Cao, J., ZnT7 can protect MC3T3-E1 cells from oxidative stress-induced apoptosis via PI3K/Akt and MAPK/ERK signaling pathways. Cell. Signal. 25:5 (2013), 1126–1135.
28. Suzuki, T., Ishihara, K., Migaki, H., Matsuura, W., Kohda, A., Okumura, K., Nagao, M., Yamaguchi-Iwai, Y., Kambe, T., Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J. Biol. Chem. 280:1 (2005), 637–643.
29. Peters, E., Heemskerk, S., Masereeuw, R., Pickkers, P., Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients. Am. J. Kidney Dis. 63:6 (2014), 1038–1048.
30. Lang, C., Murgia, C., Leong, M., Tan, L.W., Perozzi, G., Knight, D., Ruffin, R., Zalewski, P., Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:2 (2007), L577–84.